Pharmaceutical Business Review – Pharmaceutical Business Review
Pharmaceutical Business Review |
Pharmaceutical Business Review
Pharmaceutical Business Review Gene therapy firm Regenxbio has signed an agreement to acquire US-based firm Dimension Therapeutics. As per terms of the transaction, Regenxbio will pay $3.41 per Dimension share, which could be valued at around $86m. The acquisition will add … |
